Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Gut microbiota-based treatment relieved pain for patients with fibromyalgia. 

Probiotics May Effectively Treat Autoimmune Diseases 

Mohamed Cherry, MD, and Neil Kramer, MD, shed light on a phase 1 trial using CAR-T cell therapy for SLE and its potential implications for lupus treatment. 

Novel CAR-T Cell Therapy Trial for Lupus Launched by Atlantic Health System

A groundbreaking phase 1 study using CAR-T cells to treat severe lupus highlights a collaborative effort between the Cellular Therapy Program and rheumatology programs to pioneer innovative patient care.

Atlantic Health System Breaks New Ground with CAR-T Cell Therapy for Lupus Treatment

By establishing a link between endogenous retroviruses, inflammation, and autoreactive T cells in lupus, research conducted by Akiko Iwasaki, PhD, has the potential to pave the way for new targeted therapies for this complex condition.

Akiko Iwasaki, PhD: Unraveling the Role of Endogenous Retroviruses in Lupus Autoimmunity

The Xist ribonucleoprotein (RNP) complex, linked to the XX sex chromosome complement, influences the susceptibility to autoimmunity. 

Study Identifies Reasons Why Women are More Susceptible to Autoimmune Disease

The percentage of lymphocyte apoptosis in peripheral blood was significantly higher in patients with jSLE when compared with healthy controls.

Peripheral Apoptotic Lymphocytes May Predict Disease Activity in Juvenile SLE

Angus Worthing, MD, discusses the recent developments in rheumatology and his predictions for the future of treatment moving into 2024 and beyond. 

Trends and Predictions for Rheumatology in 2024, with Angus Worthing, MD

Roger A Levy, MD, PhD, discusses the transformative impact of the KDIGO guidelines, which recommend early initiation of belimumab for lupus nephritis. 

Roger A Levy, MD, PhD: The Paradigm Shift in Lupus Nephritis Management

Roger A Levy, MD, PhD, discusses the recent guideline updates regarding the treatment and management of lupus nephritis. 

Roger A Levy, MD, PhD: KDIGO Guidelines Recommend Belimumab for Lupus Nephritis

A retrospective cohort analysis suggests the monoclonal antibody may help patients with SLE reduce their reliance on oral corticosteroids over 1 year after initiating treatment.